Syntara Confirms Issuance of New Shares Under Placement
Syntara Limited (ASX: SNT) announced a price-sensitive issuance of new fully paid ordinary shares following a placement that raised capital for the company. The company issued 44,028,744 new shares at $0.06 per share as part of the two-tranche placement initially announced in December 2024. The placement was conducted without a full prospectus under the Corporations Act, consistent with regulatory requirements for such capital raises. Syntara confirmed compliance with relevant disclosure and corporate transparency obligations and stated there was no excluded information that would require separate disclosure. The funds received from the placement strengthen Syntara’s balance sheet, support ongoing operations, and advance its clinical-stage drug development programs.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to this. Read our Privacy Policy and Terms & Conditions
Syntara Confirms Issuance of New Shares Under Placement
Syntara Limited (ASX: SNT) announced a price-sensitive issuance of new fully paid ordinary shares following a placement that raised capital for the company. The company issued 44,028,744 new shares at $0.06 per share as part of the two-tranche placement initially announced in December 2024. The placement was conducted without a full prospectus under the Corporations Act, consistent with regulatory requirements for such capital raises. Syntara confirmed compliance with relevant disclosure and corporate transparency obligations and stated there was no excluded information that would require separate disclosure. The funds received from the placement strengthen Syntara’s balance sheet, support ongoing operations, and advance its clinical-stage drug development programs.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au